References
- LeQV, AbhariS, AbuzeidOM, et al. Modified natural cycle for embryo transfer using frozen-thawed blastocysts: a satisfactory option. Eur J Obstet Gynecol Reprod Biol. 2017;213:58–63. doi:10.1016/j.ejogrb.2017.04.01028437630
- TourgemanDE, SlaterCC, StanczykFZ, PaulsonRJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril. 2001;75(1):200–202. doi:10.1016/S0015-0282(00)01640-X11163838
- LiaoX, LiZ, DongX, ZhangH. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol. 2014;7(10):6992–6997.25400786
- GilmanAG. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 1990.
- BenzigerDP, EdelsonJ. Absorption from the vagina. Drug Metab Rev. 1983;14(2):137–168. doi:10.3109/036025383089913876301793
- TourgemanDE, GentzcheinE, StanczykFZ, PaulsonRJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol. 1999;180(6):1480–1483. doi:10.1016/S0002-9378(99)70042-610368494
- BenninkHJ, BoerrigterPJ. Use of dydrogesterone as a progestogen for oral contraception. Steroids. 2003;68(10–13):927–929. doi:10.1016/j.steroids.2003.07.00614667985
- MitwallyMF, DiamondMP, AbuzeidM. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer. Fertil Steril. 2010;93(2):554–569. doi:10.1016/j.fertnstert.2009.02.04719362305
- TavaniotouA, SmitzJ, BourgainC, DevroeyP. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6(2):139–148. doi:10.1093/humupd/6.2.13910782572
- FatemiHM, BourgainC, DonosoP, et al. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Human Reprod. 2007;22(5):1260–1263. doi:10.1093/humrep/del520
- ZieglerDD, FanchinR. Progesterone and progestins: applications in gynecology. Steroids. 2000;65(10):671–679. doi:10.1016/S0039-128X(00)00123-911108875
- GoldenbergRL, GrodinJM, RodbardD, RossGT. Gonadotropins in women with amenorrhea. Am J Obstet Gynecol. 1973;116(7):1003–1012. doi:10.1016/S0002-9378(16)33850-94736951
- RebarRW, EricksonGF, YenSSC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril. 1982;37(1):35–41. doi:10.1016/S0015-0282(16)45973-X6800842
- ChienLW, AuH-K, ChenPL, XiaoJ, TzengCR. Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2002;78(2):245–251. doi:10.1016/S0015-0282(02)03223-512137858
- Mohamed AmerMI, OmarOH, El Sherbiny HamedM, DahrougEG. Subendometrial blood flow changes by 3-dimensional power Doppler ultrasound after hysteroscopic lysis of severe intrauterine adhesions: preliminary study. J Minim Invasive Gynecol. 2015;22(3):495–500. doi:10.1016/j.jmig.2014.12.16525573184
- YuX, GaoC, DaiC, YangF, DengX. Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure. Reprod Biomed Online. 2019;38(5):761–767. doi:10.1016/j.rbmo.2018.12.02730885666
- NikasG, DrakakisP, LoutradisD, et al. Uterine pinopodes as markers of the ‘nidation window’ in cycling women receiving exogenous oestradiol and progesterone. Human Reprod. 1995;10(5):1208–1213. doi:10.1093/oxfordjournals.humrep.a136120
- SheshpariS, ShahnaziM, MobarakH, et al. Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review. J Transl Med. 2019;17(1):396–410. doi:10.1186/s12967-019-02149-231783875
- IllstonJD, WheelerTL, ParkerCR, ConnerMG, BurgioKL, GoodePS, RichterHE. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: serum levels and vaginal response including tissue biomarkers associated with tissue remodeling. Maturitas. 2015;81(4):475–479. doi:10.1016/j.maturitas.2015.05.01026115591
- AlexanderNJ, BakerE, KapteinM, KarckU, MillerL, ZampaglioneE. Why consider vaginal drug administration? Fertil Steril. 2004;82(1):1–12. doi:10.1016/j.fertnstert.2004.01.02515236978
- HammondGL. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab. 1995;6(9–10):298–304. doi:10.1016/1043-2760(95)00162-X18406714
- WestphalU. Steroid-Protein Interactions II. Vol. 27. Springer: Berlin, Heidelberg; 1986.
- SudomaI, GoncharovaY, ZukinV. Optimization of cryocycles by using pinopode detection in patients with multiple implantation failure: preliminary report. Reprod Biomed Online. 2011;22(6):590–596. doi:10.1016/j.rbmo.2011.02.00421493157
- KankiS. Cyclic changes in steroid hormone concentration and steroid hormone receptor in the human endometrium. Nihon Sanka Fujinka Gakkai Zasshi. 1982;34(12):2177–2184.7153595
- LiuSM, ZhouYZ, WangHB, et al. Factors associated with effectiveness of treatment and reproductive outcomes in patients with thin endometrium undergoing estrogen treatment. Chin Med J. 2015;128(23):3173–3177. doi:10.4103/0366-6999.17025826612292